Hormone therapy and endometrial angiogenesis

Climacteric

Volumn 6, Issue 4, 2003, Pages 273-277

  Mirkin, Sebastian ^a,b   Navarro, Francisco ^a   Archer, David F ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b The Jones Institute for Reproductive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ESTRADIOL; GESTAGEN; HORMONE DERIVATIVE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESSENGER RNA; NORETHISTERONE; PROGESTERONE; THROMBOSPONDIN 1; VASCULOTROPIN;

ANGIOGENESIS; DRUG SAFETY; ENDOMETRIUM; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; IN VIVO STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; UTERUS BLEEDING;

EID: 1642456611     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.6.4.273.277     Document Type: Review

References (31)

1. Al-Azzawi F, Habiba M. Regular bleeding on hormone replacement therapy: a myth? Br J Obstet Gynaecol 1994;101:661-2
2. Limouzin-Lamothe MA. What women want from hormone replacement therapy: results of an international survey. Eur J Obstet Gynecol Reprod Biol 1996;64(Suppl):S21-4
3. Archer DF, Pickar JH. The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data. Climacteric 2002;5:45-59
4. Newton KM, LaCroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. Women's beliefs and decisions about hormone replacement therapy. J Womens Health 1997;6:459-65
5. Rees M, Hague S, Oehler MK, Bicknell R. Regulation of endometrial angiogenesis. Climacteric 1999;2:52-8
6. Wahab M, Thompson J, Al-Azzawi F. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis. Hum Reprod 2000;15:2075-81
7. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW, Iruela-Arispe ML. Progesterone regulates proliferation of endothelial cells. J Biol Chem 1999;274:2185-92
8. Johannisson E, Landgren BM, Diczfalusy E. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 microgram norethisterone (NET) minipill. Contraception 1982;25:13-30
9. Laoag-Fernandez JB, Maruo T, Pakarinen P, Spitz IM, Johansson E. Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. Hum Reprod 2003;18:694-9
10. McGavigan CJ, Dockery P, Metaxa-Mariatou V, et al. Hormonally mediated disturbance of angiogenesis in the human endometrium after exposure to intrauterine levonorgestrel. Hum Reprod 2003;18:77-84
11. Hourihan HM, Sheppard BL, Bonnar J. The morphological response of blood vessels of the endometrium to low dose oral norethisterone and levonorgestrel. J Obstet Gynaecol 1991;11: 47-56
12. Roopa BA, Loganath A, Singh K. The effect of a levonorgestrel-releasing intrauterine system on angiogenic growth factors in the endometrium. Hum Reprod 2003;18:1809-19
13. Mathur R, Smith SK. Endometrial angiogenesis: physiology and clinical implications. J Fam Plann Reprod Health Care 2002;28:173-4
14. Sivridis E. Angiogenesis and endometrial cancer. Anticancer Res 2001;21:4383-8
15. Kapiteijn K, Koolwijk P, Van Der Weiden R, Helmerhorst F, Kooistra T, Van Hinsbergh VW. Steroids and cytokines in endometrial angiogenesis. Anticancer Res 2001;21:4231-42
16. Gargett CE, Rogers PA. Human endometrial angiogenesis. Reproduction 2001;121:181-6
17. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-64
18. Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Hum Reprod Update 1998;4:509-19
19. Seki N, Kodama J, Hashimoto I, Hongo A, Yoshinouchi M, Kudo T. Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis. Int J Oncol 2001; 19:305-10
20. Torry DS, Holt VJ, Keenan JA, Harris G, Caudle MR, Torry RJ. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril 1996;66:72-80
21. Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999;103:159-65
22. Smith SK. Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 2001; 12:147-51
23. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 2000;60:3183-90
24. Cullinan-Bove K, Koos RD. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993;133:829-37
25. Lawler J. Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 2002;6:1-12
26. Iruela-Arispe ML, Porter P, Bornstein P, Sage EH. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 1996;97:403-12
27. Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix metalloproteinase. 2. Regulation of metalloproteinase activity. J Biol Chem 2000;275:32167-73
28. Navarro FJ, Mirkin S, Archer DF. Effect of raloxifene, 17beta-estradiol, and progesterone on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells. Fertil Steril 2003;79:1409-15
29. Mirkin S, Mahony MC, Archer DF. Effect of tibolone and its metabolites on mRNA for vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 in Ishikawa cells. Menopause 2003;in press
30. Archer DF, Navarro F, Mirkin S. Effect of levonorgestrel, medroxyprogesterone acetate, norethindrone and 17 beta estradiol on mRNA for vascular endothelial growth factor isoforms 121 and 165. Fertil Steril 2003;in press
31. Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81:3112-18